Concept
FCV: Full respiratory control
Ventinova’s new ventilation technique FCV®is unique in controlling the inspiration as well as the expiration phase during artificial ventilation of a patient. This is established by generating a continuous flow into the patient’s lungs during inspiration or a continuous (negative) flow, sucking gasses out of the patient’s lungs. The continuous flow either into the lungs or out of the lungs, without ventilation pauses, results in linear increases and decreases in intratracheal pressures.
Small Lumen
FCV enables ventilation through small bore and high resistant tubes, with an inner diameter of <3 mm. in open and obstructed (sealed) airways. Therewith it has saved lives in CICO situations and it has provided numerous new possibilities for surgical treatment, especially during ENT or oral surgery: the surgeon has a hygienic and clear sight and a spacious surgical exposure.
Higher Efficiency
FCV ventilation is based on creating linear increases and decreases in intratracheal pressures. As a result, the mean airway pressure will be higher as to be compared to conventional large bore Volume Controlled Ventilation or Pressure Controlled Ventilation. Therewith bronchiole and alveoli will be kept more open during ventilation facilitating oxygen uptake in the blood. Moreover, the continuous gas flow enhances gas mixture in the lungs also improving gas exchange. All together FCV results in a higher efficient ventilation as compared to conventional ventilation techniques.
Lower Energy
FCV is based on a controlled, stable flow generating with pressures at the tip of the endotracheal tube just high enough to generate a linear increase intratracheal pressure during inspiration and a pressure just low enough to generate a linear decrease in intratracheal pressure during expiration. This is in contrast to Pressure Controlled Ventilation and Volume Controlled Ventilation where, especially during the passive expiratory phase, large intratracheal pressure drops are observed due to the instant pressure caused by collapsing thoracic wall.
OUR Mission:
Let’s redefine ventilation.
Together, we question, we create, we care, we educate, we celebrate
Patient ventilation with minimal impact and maximal control
We are VENTINOVA.
Do you want to know more about us or our products?
LATEST NEWS
First clinical study on FCV® using Evone® and Tritube® presented as one of the five most important publications concerning preoperative ventilation
Dr. Bluth, University Hospital Dresden, presents the first clinical study on FCV® using Evone® and Tritube® as one of the five most important publications concerning preoperative ventilation. This study, conducted at Universitätsklinikum Freiburg and...
SIGN UP FOR OUR NEWSLETTER:
CONTACT US
Ventinova Medical
Meerenakkerplein 7
5652 BJ Eindhoven (NL)
T. +31 (0)40 7516020
E. info@ventinova.nl
Chamber of Commerce: 58307834